Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Tranylcypromine manufacturers

4 products found

Filters

4 products found

tranylcypromine

Tablets, film coated 10 mg, 20 mg, 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
Germany , United Kingdom , Vietnam
Available for
Distribution only
Comments
Ref. Parnate
Manufacturer #269

A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 1 days

tranylcypromine

Tablets 10 mg, 20 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Norway , Sweden
Manufacturer #34084

Established in 1994, this family-owned, independent pharmaceutical manufacturer specializes in developing, manufacturing, and supplying high-quality generic and over-the-counter (OTC) pharmaceuticals. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards. The company offers a diverse and continually growing range of generic products, from specialist, niche items to widely sought-after molecules in multiple dosage forms, providing exceptional quality at an affordable price. Its ever-increasing portfolio of high-quality OTC products spans various therapeutic areas, including pain relief, travel, dental care, infection, gut health, and baby care. Operating advanced production lines adhering to stringent GMP guidelines, the manufacturer distributes its products across the UK and beyond.

Manufacturer usually replies in 2 days

tranylcypromine

Tablets, immediate release (IR) 10mg, 20mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, MHRA
Unavailable markets
Australia , Denmark , Finland , New Zealand , Norway , Sweden , United Kingdom
Registered in
Denmark , Finland , Norway , Sweden , United Kingdom
Available for
Licensing with supply, Technology transfer
Manufacturer #29671

Established in 2010, this GMP manufacturer is a CTD dossier owner and manufacturer, providing comprehensive pharmaceutical services to clients worldwide. Specializing in end-to-end product development, it operates state-of-the-art facilities in Goa, India, adhering to international GMP standards. As a CTD dossier owner and manufacturer, it offers services including formulation development, analytical method validation, stability studies, and clinical batch manufacturing. This GMP manufacturer, as a CTD dossier owner and manufacturer, holds WHO-GMP certification and has received TGA certification from Australian authorities for its manufacturing facility.

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

TRANYLCYPROMINE MANUFACTURERS

Tranylcypromine is an antidepressant, more specifically a monoamine oxidase inhibitor. This medication treats depression by restoring the balance of certain natural substances or neurotransmitters in the brain. It helps to improve your mood and feelings of well-being. A propylamine is generally formed from the cyclization of the side chain of amphetamine. Usually, monoamine oxidase inhibitor is effective in the treatment of: major depression, dysthymic disorder, and atypical depression. panic and phobic disorders Tranylcypromine is basically a kind of racemate that comprises equal amounts of (1R,2S)- and (1S,2R)-2- phenylcyclopropane -1- amine along with the chiral centers both located on the cyclopropane ring. This is actually an irreversible monoamine oxidase inhibitor that is used as an antidepressant. Tranylcypromine is a non-hydrazine monoamine oxidase inhibitor with a rapid onset of activity. MAO is an enzyme which functions to catalyze the oxidative deamination of a number of: amines, including serotonin, norepinephrine, epinephrine, and dopamine. There are two forms of MAO such as A and B which are found in the body. MAO-A is mainly found within cells located in the periphery. It catalyzes the breakdown of serotonin, norepinephrine, epinephrine, dopamine, and tyramine. MAO-B functions on norepinephrine, epinephrine, phenylethylamine, dopamine, and tyramine. It is localized extracellularly and is found predominantly in the brain. Although the mechanism of MAOIs is still unclear. It is thought that the functions in increasing free serotonin and norepinephrine concentrations by altering the concentrations of other amines in the CNS. It has been found that depression is caused by low levels of serotonin and/or norepinephrine and that increasing serotonergic and norepinephrinergic neurotransmission results in the relief of depressive symptoms. MAO-A inhibition is actually more relevant to antidepressant activity than MAO B inhibition. Very few MAO-B inhibitors have no antidepressant effects. In overdosage, some patients exhibit: insomnia, restlessness and anxiety, progressing in severe cases to agitation, mental confusion and incoherence. Hypotension, dizziness, weakness, and drowsiness, in extreme cases to extreme dizziness and shock. Very few patients are found to have hypertension with severe headaches and other symptoms.It is rare in reports that hypertension was accompanied by twitching or myoclonic fibrillation of skeletal muscles with hyperpyrexia. sometimes which progresses to generalized rigidity and coma.

HOW DOES TRANYLCYPROMINE WORK?

Tranylcypromine eccentrically and without any reverse inhibits monoamine oxidase.MAO, only within neurons appears to regulate the levels of monoamines released upon synaptic firing. Depression is basically associated with low levels of monoamines. The inhibition of MAO serves to ease depressive symptoms when it results in an increase in the concentrations of these amines within the CNS.

WHOLESALE PRICE OF TRANYLCYPROMINE

The lowest price for the common version of tranylcypromine oral tablet 10 mg is around $170 for a supply of 100 tablets. The price may vary and depends on the pharmacy you visit.

Sourcing TRANYLCYPROMINE Manufacturers and TRANYLCYPROMINE Sublicensing

Those who are looking for an easy and convenient way to source and order tranylcypromine may search online using Pipelinepharma's marketplace. Through our strict evaluation and quality control process, you are assured to find verified tranylcypromine manufacturers and suppliers. Pipelinepharma is a global pharmaceutical licensing marketplace that lets buyers and distributors find suppliers and manufacturers of tranylcypromine and other pharmaceutical products. Instead of traveling to conferences and meetings to find new companies to do business with, you can find them within a few clicks.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible